普伐他汀在年龄60至85岁、低密度脂蛋白胆固醇>160mg/dl患者中的疗效和安全性。
The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
作者信息
Glasser S P, DiBianco R, Effron B A, Faas F, Germino F W, Shane L E, Unger A H, Staggers J E
机构信息
University of South Florida Health Sciences Center, USA.
出版信息
Am J Cardiol. 1996 Jan 1;77(1):83-5. doi: 10.1016/s0002-9149(97)89140-0.
PMID:8540464
Abstract
This study demonstrated that pravastatin 20 mg once daily significantly lowered total cholesterol (by 19%) and LDL cholesterol by 25%.
摘要
这项研究表明，每日一次服用20毫克普伐他汀可显著降低总胆固醇（降低19%）和低密度脂蛋白胆固醇（降低25%）。
Zotero 插件